09:53 AM EST - Intellipharmaceutics International Inc. : Reported the results of operations for the year ended November 30, 2016. All dollar amounts referenced herein are in United States dollars. The Company recorded revenues of $2.2 million for the year ended November 30, 2016 versus $4.1 million for the year ended November 30, 2015. The Company recorded net loss of $10.1 million or $0.38 per common share, compared with a net loss of $7.4 million or $0.31 per common share for the prior year. Intellipharmaceutics International Inc.
shares T.I are trading down $0.26 at $3.37.
